Your IND


How can we help you bring your molecule to the clinic?

From DNA to TOX drug substance in 5 months* and IND in 11 months*

Minimum 1.5 kg GMP drug substance for your phase 1 clinical studies*

Flexible commercial terms

Improved portability


Progress with promise 

  • Our new comprehensive DNA-to-IND program combines speed and quality, while minimizing risk, guaranteeing* delivery of a CMC path to IND with your monoclonal antibodies in just 11 months.
  • To gain maximum information on your drug candidate as early as possible, your tox drug substance is delivered in only five months allowing you to perform toxicological studies before entering GMP manufacturing

Need more information, 
download our white paper to discover 
what Ibex® Design can do for you.

*For antibodies, from DNA transfection to delivery of CMC enabling IND activities. Subject to terms and conditions.


© 2023 Lonza. All rights reserved.